# CVE-2024-10476: Hardcoded credentials in BD BACTEC™ Blood Culture System

> Attackers can use default credentials to access, modify, or delete sensitive medical data and disrupt system availability in BD diagnostic products.

- **Severity:** High 8.0 (`CVSS:3.1/AV:A/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H`)
- **Exploited in the wild:** Not known
- **Login needed:** Any signed-in user
- **Attackable:** Local or same network only
- **Victim action needed:** Not needed
- **Fix available:** No
- **Published:** 17 Dec 2024
- **Updated:** 17 Dec 2024
- **Also known as:** GHSA-2qgh-37rm-mv6x

## What is CVE-2024-10476?

CVE-2024-10476 is a high-severity vulnerability in Becton Dickinson & Co BD BACTEC™ Blood Culture System, published on 17 Dec 2024. It can only be exploited from the same machine or local network, with no action from the victim.

### Official description

Default credentials are used in the above listed BD Diagnostic Solutions products. If exploited, threat actors may be able to access, modify or delete data, including sensitive information such as protected health information (PHI) and personally identifiable information (PII). Exploitation of this vulnerability may allow an attacker to shut down or otherwise impact the availability of the system. Note: BD Synapsys™ Informatics
Solution is only in scope of
this vulnerability when
installed on a NUC server. BD Synapsys™
Informatics Solution installed
on a customer-provided virtual machine or on the BD Kiestra™ SCU hardware is
not in scope.

Weakness: CWE-1392 (Use of Default Credentials)

## Which versions are affected by CVE-2024-10476?


## How do I fix CVE-2024-10476?

No fix has been published for CVE-2024-10476 yet. Limit exposure of the affected software until one is available.

## Is CVE-2024-10476 being exploited?

There is no known exploitation of CVE-2024-10476 in the wild and no public exploit code.

## Fix prompt for AI coding agents

```text
Check this codebase for CVE-2024-10476 and fix it if it is affected.

What it is: CVE-2024-10476 is a high-severity vulnerability in Becton Dickinson & Co BD BACTEC™ Blood Culture System, published on 17 Dec 2024. It can only be exploited from the same machine or local network, with no action from the victim.
Exploitation: There is no known exploitation of CVE-2024-10476 in the wild and no public exploit code.

Affected product: Becton Dickinson & Co BD BACTEC™ Blood Culture System. No package-level version data is available, so check the vendor advisory linked from the reference page.

Task:
1. Search the dependency manifests and lockfiles (for example package.json, package-lock.json, requirements.txt, poetry.lock, uv.lock, pom.xml, build.gradle, go.mod, Cargo.lock, Gemfile.lock) and any Dockerfiles for the affected packages, including transitive dependencies.
2. If an affected version is in use, upgrade it to the fixed version for its release line with the project's package manager, so the lockfile is regenerated. Prefer the smallest upgrade that fixes it.
3. If there is no fix, or the upgrade would break the build, do not guess: explain the risk and the safest workaround instead.
4. Run the tests and summarise what changed and why.
5. If nothing in the project is affected, say so and change nothing.

Reference: https://insights.sbomify.com/CVE-2024-10476/ (Markdown: https://insights.sbomify.com/CVE-2024-10476/index.md)
```

## Sources

- CVE record: https://www.cve.org/CVERecord?id=CVE-2024-10476
- NVD: https://nvd.nist.gov/vuln/detail/CVE-2024-10476
- OSV: https://osv.dev/vulnerability/CVE-2024-10476

---
From sbomify Insights: https://insights.sbomify.com/CVE-2024-10476/
Summaries are generated and may contain mistakes; the official description above is the record.